Statement Of Changes In Equity [Abstract]

Egetis Therapeutics - Filing #678413

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	5,456,000,000 SEK	—	1 266,5 SEK	167,000,000 SEK	—	—	154,000,000 SEK	—	1 780,0 SEK	5,062,000,000 SEK	—	—	—	—	61,000,000 SEK	9,396,000,000 SEK	113,000,000 SEK	1 428,4 SEK	—	7,458,000,000 SEK	13,000,000 SEK	1 262,8 SEK	5,270,000,000 SEK	87,000,000 SEK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	3,269,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	1,938,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—
Other comprehensive income	1,000,000 SEK	—	—	—	—	—	—	—	—	—	—	—	—	0 SEK	—	—	—	—	—	—	—	—	—	—	—
Comprehensive income	3,270,000,000 SEK	—	- SEK	—	—	3,270,000,000 SEK	- SEK	—	- SEK	—	—	- SEK	- SEK	1,938,000,000 SEK	1,938,000,000 SEK	—	—	—	—	- SEK	—	—	—	—	—
Issue of equity	3,819,000,000 SEK	—	- SEK	—	—	- SEK	41,000,000 SEK	—	3,778,000,000 SEK	—	—	26,000,000 SEK	- SEK	1,808,000,000 SEK	- SEK	—	—	—	—	1,781,000,000 SEK	—	—	—	—	—
Increase (decrease) through other changes, equity	34,000,000 SEK	—	34,000,000 SEK	—	—	- SEK	- SEK	—	- SEK	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	72,000,000 SEK	—	72,000,000 SEK	—	—	- SEK	- SEK	—	- SEK	—	—	- SEK	48,000,000 SEK	48,000,000 SEK	- SEK	—	—	—	—	- SEK	—	—	—	—	—